PMA device
Cardiomems
Abbott Medical · System, Hemodynamic, Implantable (MOM, Class III) · First FDA decision Apr 29, 2016, newest Apr 29, 2016Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
32
Naming "Cardiomems"
MAUDE reports
6,203
Brand "Cardiomems", since 2015
PubMed studies
260
Mentioning "Cardiomems"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cardiomems
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- CARDIOMEMSPMA supplement
P100045-S006 · Decided Apr 29, 2016 · 252 days after receipt · Normal 180 Day Track No User Fee
Device type: System, hemodynamic, implantable (MOM) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Cardiomems", any status and sponsor, newest update first.
- Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailurePivotal-lookingRecruiting
Abbott Medical DevicesPublic (ABT)
NCT06526195 · 850 participants (planned) · Start Dec 13, 2024 · Primary completion Sep 2029
Device: CardioMEMS HF System; HeartMate 3 Left Ventricular Assist System · For: Heart Failure; Heart Diseases; Cardiovascular Diseases and 1 more
Sites: Phoenix, Arizona; Little Rock, Arkansas; Sacramento, California · 70 sites in all
Centre Hospitalier Universitaire de NīmesAcademic, hospital or other
NCT05428631 · 4 participants · Start Aug 2, 2022 · Primary completion Oct 25, 2023
Device: Implantation of the CARDIOMEMS™ HF device · For: Heart Failure; Renal Insufficiency
Sites: Nîmes, France; Montpellier, France
Sheffield Teaching Hospitals NHS Foundation TrustAcademic, hospital or other
NCT04078243 · 120 participants (planned) · Start Jan 21, 2020 · Primary completion Jan 6, 2028
Device: CardioMEMS HF System · For: Pulmonary Hypertension
Sites: Sheffield, United Kingdom
29 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cardiomems", and for the whole product code for context.
This brand
6,203 reports: 6,066 malfunction, 123 injury, 10 death
Whole product code MOM
12,295 reports: 7,687 malfunction, 4,377 injury, 226 death
Newest reports for this brand
- CARDIOMEMS PATIENT ELECTRONIC SYSTEMMalfunction
3004936110-2026-01861 · Received Oct 29, 2026 · Event dated Oct 23, 2026
Device type: System, Hemodynamic, Implantable (MOM)
Device problem as coded: Material Frayed
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- CARDIOMEMS PATIENT ELECTRONIC SYSTEMMalfunction
3004936110-2026-01860 · Received Oct 29, 2026 · Event dated Oct 19, 2026
Device type: System, Hemodynamic, Implantable (MOM)
Device problem as coded: Material Frayed
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- CardioMEMS HERO DeviceInjury
3004936110-2026-01851 · Received Oct 29, 2026 · Event dated Aug 3, 2026
Device type: System, Hemodynamic, Implantable (MOM)
Device problem as coded: Incorrect Measurement
Patient problem as coded: Dyspnea; Weight Changes; Hypervolemia
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1427-2025 · Started Feb 3, 2025 · Posted by FDA Mar 21, 2025
Reason given: Due to issues associated with data migration of patient information and results to a Cloud service, the firm has received complaint associated with some patient profile information being duplicated while other patient information is missing.
Cause as FDA categorized it: Software design · Device type: System, Hemodynamic, Implantable (MOM)
Z-0987-2025 · Started Nov 6, 2024 · Posted by FDA Jan 17, 2025
Reason given: Due to a data migration from on-premises server to the cloud environment, some customers reported that they were not able to transmit readings.
Cause as FDA categorized it: Under Investigation by firm · Device type: System, Hemodynamic, Implantable (MOM)
Z-0988-2025 · Started Oct 5, 2024 · Posted by FDA Jan 17, 2025
Reason given: As a result of a cloud data migration of Patient and Hospital Electronic Systems (PES and HES) reverted to an outdated configuration causing incorrect/inaccurate pulmonary artery (PA) pressure readings.
Cause as FDA categorized it: Under Investigation by firm · Device type: System, Hemodynamic, Implantable (MOM)
10 more recall records with a free account
Published research
The most relevant PubMed records for "Cardiomems"[tiab]. The summary above synthesizes these.
- [Not Available].
Brandner J, Meyer P, Noble S, et al. · Rev Med Suisse · 2025English Abstract
- CardioMEMSࡊ: a tool for remote hemodynamic monitoring of chronic heart failure patients.
Radhoe SP, Brugts JJ · Future Cardiol · 2022Review
- Discordant Pressure-Volume Trends During CardioMEMS Monitoring.
Kittipibul V, Fudim M, Silver MA, et al. · JACC Heart Fail · 2023Letter, Research Support, Non-U.S. Gov't
- The CardioMEMS Heart Failure System for chronic heart failure - a European perspective.
Radhoe SP, Clephas PRD, Mokri H, et al. · Expert Rev Med Devices · 2023Review
- The favourable alliance between CardioMEMS and levosimendan in patients with advanced heart failure.
Visco V, Esposito C, Rispoli A, et al. · ESC Heart Fail · 2024Research Support, Non-U.S. Gov't
- CardioMEMS HF for the Management of Heart Failure-Effectiveness and Value.
Ollendorf DA, Sandhu AT, Pearson SD · JAMA Intern Med · 2016Research Support, Non-U.S. Gov't, Review
- Reply to Imamura.
Veenis JF, Brugts JJ · Eur J Cardiothorac Surg · 2020Letter, Comment
- CardioMEMS Implantation Using Gadolinium-based Contrast Agent: A Case Report.
Rali AS, Stevenson LW, Zalawadiya SK · Card Fail Rev · 2021Review
- Sex Differences in CardioMEMS Utilization and Impact on Readmissions and Mortality in Heart Failure Patients.
Markson F, Abe TA, Adedinsewo D, et al. · JACC Heart Fail · 2023Letter, Research Support, N.I.H., Extramural
- CardioMEMS Heart Failure System: An Up-to-Date Review.
Tolu-Akinnawo O, Akhtar N, Zalavadia N, et al. · Cureus · 2025Review
- CardioMEMS: where we are and where can we go?
Pour-Ghaz I, Hana D, Raja J, et al. · Ann Transl Med · 2019Review
- Current Role of the CardioMEMS Device for Management of Patients with Heart Failure.
Leung CC · Curr Cardiol Rep · 2019Review
Other devices of this type
Also filed under product code MOM.
- CardioMEMS HF SystemAbbott Medical · PMA 2026
- Cordella Pulmonary Artery Sensor SystemEndotronix, Inc. · PMA 2026
- Cardiomems HF Pressure Measurement SystemAbbott Medical · PMA 2016
- Next Gen Patient System CM1200 CardioMEMS HERO DeviceAbbott Medical · PMA 2026
- CorPASS SystemEndotronix, Inc. · PMA 2025
- CardioMEMS patient and hospital electronicsAbbott Medical · PMA 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.